Health Canada approval of new ALS drug allows Canadians to get access first - The Globe and Mail
/cloudfront-us-east-1.images.arcpublishing.com/tgam/CW5AAGBQ7BLYJN3V6GAFALKZLE.jpg)
6/13/2022 12:00:00 AM2 years 10 months ago
by Carly Weeks
by Carly Weeks
ALS patients and researchers celebrate the news of Health Canada approving a new ALS drug from Amylyx Pharmaceuticals, the first regulator in the world to do so
Health Canada gave Albrioza the green light on a conditional basis.Sean Kilpatrick/The Canadian Press Health Canada has become the first regulator in the world to approve a new amyotrophic lateral s… [+4875 chars]
full article...